Wed, Sep 23 11:23 AM

Guggenheim upgrades Editas Medicine stock rating on gene editing therapy

Investing.com•Wed, Sep 23, 2026, 11:12 AM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/analyst-ratings/guggenheim-upgrades-editas-medicine-stock-rating-on-gene-editing-therapy-93CH-4912716)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #guggenheim #upgrades #editas #medicine #stock #rating #gene #editing

More Headlines

FinanceMarketWatch• 5m ago

Why CoreWeave’s beaten-down stock could be due for a major comeback

CoreWeave shares have tumbled almost 40% from their May highs as debt fears spooked investors. But one analyst believes the selloff has been overblown.

FinanceMarketWatch• 9m ago

Financial stocks are falling as rates rise. Why that’s a problem for the broader market.

Higher interest rates could slow loan growth and raise banks’ funding costs

FinanceInvesting.com• 9m ago

General Mills beats first-quarter sales estimates

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 9m ago

China’s central bank to inject $149 billion daily before holidays

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 9m ago

Trump plans grand spectacle for potentially tense Xi talks

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 10m ago

UBS reiterates Buy on Royal Caribbean stock on TUI cruise data

Developing story — details emerging. Check the source link for the latest updates.